This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

NSH and Dr. James McCormick celebrate special anniversaries in 2013
NSH
The National Society for Histotechnology will celebrate its 40th anniversary in October just weeks after the end of this year's Symposium/Convention. 2013 also marks the 50th Anniversary of the U.S. Patent "Apparatus for Mounting a Specimen" (the "Tissue-Tek" embedding center) held by Dr. James McCormick, FCAP, FACHE. McCormick is a pathologist, inventor, consultant to the scientific and healthcare industry and a 30-plus year member of the National Society for Histotechnology. He is author of "18th-Century Microscopes: A Synopsis of History and Workbook" as well as many peer reviewed health science papers. Dr. and Mrs. McCormick founded Science Heritage Ltd. in 1975 to support their large collection of antique microscopes, natural science artifacts, and prepared microscope slides. For the past 33 years, Science Heritage Ltd. has sponsored the annual NSH J.B. McCormick, MD Award. This award is presented to an NSH member in recognition of outstanding and exceptional service to the National Society for Histotechnology.

To celebrate the 40th Anniversary of NSH and the golden anniversary of McCormick's embedding center patent the NSH Convention Committee is offering two hands on interactive wet workshops presented by McCormick and his colleagues. Learn more.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TOP STORIES


Research casts doubt on Parkinson's disease treatment
Chicago Tribune
A recent study questions long-held assumptions about the way a brain protein affects the progression of Parkinson's disease. Researchers in 1997 linked Parkinson's with the protein alpha-synuclein. They began looking for ways to block it to slow the progression of the disease, which is characterized by such symptoms as tremors, rigidity, trouble walking and slowness of movement and affects more than a million Americans. Demetrius Maraganore, a neurologist at NorthShore University HealthSystem in Evanston, has been working with Mayo Clinic researchers to study that brain protein, focusing on its relationship to two key effects of Parkinson's disease: motor and cognitive impairment and dementia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Human stem cells give rise to brain-like organs in culture
Medscape
Human "cerebral organoids" grown in culture from stem cells are revealing the steps of early normal neurogenesis and the origins of microcephaly, according to a report published online recently in Nature. The cerebral organoids join a growing list of human body parts modeled in cell culture, including the human retina, intestines, pituitary gland and liver.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Novel metabolic imaging method enhances prostate cancer diagnoses
The Medical News
Metabolic imaging with hyperpolarized pyruvate is a noninvasive and well-tolerated method for visualizing prostate tumors, U.S. scientists have shown. In Science Translational Medicine, the team says their findings "will be valuable for noninvasive cancer diagnosis and treatment monitoring in future clinical trials."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Promising stem cell treatment for neonatal brain injury and stroke
By Dr. Afsaneh Motamed-Khorasani
Human umbilical cord blood is a rich source of stem cells, which could be potentially used for the treatment of hematopoietic diseases. Ischemic brain damage is a major cause of mortality and severe neurologic disability. Recently, the use of human umbilical cord blood for the treatment of neonatal hypoxic-ischemic brain injury and ischemic stroke has been explored in several studies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
Spring Bioscience - BRAF V600E


Spring Bioscience is leading the research industry by pioneering novel, next generation antibodies that can differentiate mutant and normal protein, enabling pathologists to see relevant mutations within their cellular context. Having already released Exon19 and EGFR L858R for exclusive use by Ventana Medical Systems, Spring Bioscience has launched BRAF V600E.
Click here to find out more.
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more
Stellaris RNA FISH Probes


Stellaris RNA FISH is a new research technology that enables direct detection, localization and quantification of RNA. The low cost per assay, simple protocol, and the ability to localize mRNA and lncRNA to organelles and cellular structures provides obvious benefits for life science research. Custom and catalogued probes sets available. MORE


IN THE NEWS


Copper identified as Culprit in Alzheimer's Disease
Virtual Medical Centre
Copper appears to be one of the main environmental factors that trigger the onset and enhance the progression of Alzheimer's disease by preventing the clearance and accelerating the accumulation of toxic proteins in the brain. That is the conclusion of a recent study in the journal Proceedings of the National Academy of Sciences.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Breakthrough model holds promise for treating Graves' disease
Science Daily
Researchers have developed the first animal model simulating the eye complications associated with the thyroid condition Graves' disease, a breakthrough that could pave the way for better treatments, according to a recent study accepted for publication in The Endocrine Society's journal Endocrinology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Blind mole-rats are resistant to chemically induced cancers
R&D Magazine
Like naked mole-rats, blind mole-rats (of the genus Spalax) live underground in low-oxygen environments, are long-lived and resistant to cancer. A new study demonstrates just how cancer-resistant Spalax are, and suggests that the adaptations that help these rodents survive in low-oxygen environments also play a role in their longevity and cancer resistance.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


An easier way to control genes
R&D Magazine
Massachusetts Institute of Technology researchers have shown that they can turn genes on or off inside yeast and human cells by controlling when DNA is copied into messenger RNA — an advance that could allow scientists to better understand the function of those genes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Problems with IHC? Try RNA-ISH.
Affymetrix’ QuantiGene® ViewRNA Assays deliver unbeatable specificity for your target of interest in archival FFPE tissue sections. Be amazed.
Produce the best IHC results

Download your IHC application guide and discover reagents to support every stage of your IHC workflow. Visit Abcam at Booth 4 at ECP 2013. DOWNLOAD NOW


Magnetic nanoparticles for drug delivery
By Dr. Afsaneh Motamed-Khorasani
Targeted drug delivery is a major problem for the treatment of many diseases. Magnetic nanoparticles, or MNPs, can be considered as promising drug-delivery candidates due to their special properties. They can be handled easily by an external magnetic field and can be delivered by passive and active strategies. Furthermore, visualization has become easy in MRI scans due to the use of MNP. However, there are some drawbacks to the use of MNPs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ethical questions linger in cervical-cancer study
The Arizona Republic via USA Today
Researchers found that a simple test had cut the rate of death from cervical cancer, but the study included a control group in which women were monitored but not screened or routinely treated.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword CERVICAL CANCER.


  FEATURED COMPANIES
Intelsint Vacuum Tissue Processors
A line of TPs capable to conveniently cover the needs of every Histology lab. Our attention is focused on reliability, flexibility, ease of usage, samples protection and user safety.

Please visit us at www.intelsint.it
Sakura Smart Automation
Our singular focus is to optimize histology workflow. Rapid tissue-processing, Automated Embedding, and real-time specimen review are just a few of our many innovations.


Drexel researchers develop therapeutic ultrasound technology for healing chronic wounds
Drexel Now
In hopes of helping patients suffering from extremely slow-healing injuries, called chronic wounds, researchers from Drexel's School of Biomedical Engineering, Science and Health Systems and College of Medicine are taking a new approach to using ultrasound as a healing tool. By dialing down the energy level on therapeutic ultrasound, similar to that used to treat athletes' muscle and ligament injuries, the team is finding a solution that could give the body's natural healing process a boost and could save patients a great deal of time, money and suffering.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    In regenerative medicine breakthrough, lab-grown human heart tissue beats on its own (The Verge)
Disturbing thyroid cancer rise in Fukushima minors (RT)
New ovarian cancer screening test offers hope for early detection (Live Science via Fox News)
New therapy strategy for breast cancer that has spread to the brain (Oncology Nurse Advisor)

Don't be left behind. Click here to see what else you missed.


  PRODUCT SHOWCASES
RNAscope: Visualize Single-Copy RNA

RNAscope FFPE Assay Kits make detecting single-copy RNA easy. RNAscope works for virtually any gene in any tissue!

• Exquisite sensitivity & specificity
• Optimized for archival FFPE tissue
• Easy 7-hour IHC-like workflow
• Quantifiable and automatable
• New assays in < 3="">
• Guaranteed assay performance
Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact James DeBois at 469-420-2618

More info
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 4, 2013
Aug. 28, 2013
Aug. 21, 2013
Aug 20, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063